Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-012394

EVP and Chief Medical Officer sold 3,505 shares at an average $9.69 ($33,955)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eisner Mark EVP and Chief Medical Officer 2026-02-24 Sale 10b5-1 −1,616 $9.53 $15,405 155,913 D
Eisner Mark EVP and Chief Medical Officer 2026-02-25 Sale 10b5-1 −1,889 $9.82 $18,550 154,024 D
Open-market sales · 3,505 sh · avg $9.69 · $33,955
Loading xslF345X05/wk-form4_1772142916.xml…